EU agency backs Novartis' Votubia for kidney tumors

ZURICH (Reuters) - European regulators on Friday recommended approval of a Novartis' drug Votubia for the treatment of non-cancerous kidney tumors in patients with a rare genetic disease known as tuberous sclerosis complex (TSC). The Committee...

Source: http://health.yahoo.net/news/s/nm/eu-agency-backs-novartis-votubia-for-kidney-tumors

Jorja Fox history Facebook funny